Voting Rights Announcements | 8 April 2014 10:49


STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG 

08.04.2014 10:49

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Notification of voting rights pursuant to sec. 25 WpHG
We received the following notification pursuant to sec. 25 WpHG on April
04, 2014:

1. Listed company:
STADA Arzneimittel AG
Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

2. Notifier:
Deutsche Asset & Wealth Management Investment GmbH, Frankfurt, Germany 

3. Triggering event:
Exceeding Threshold

4. Threshold(s) crossed or reached:
5%

5. Date at which the threshold is crossed or reached:
27.03.2014

6. Total amount of voting rights:
5.66% (equals 3423948 voting rights)
calculated from the following total number of voting rights issued:
60442500

7. Detailed information on the voting rights proportion:

Voting rights proportion based on financial/other instruments pursuant to
sec. 25 WpHG:
0.18% (equals 107097 voting rights)
thereof held indirectly:
0% (equals 0 voting rights)

Voting rights pursuant to sec. 21, 22 WpHG:
5.49% (equals 3316851 voting rights)

8. Detailed information on financial/other instruments pursuant to sec. 25
WpHG:

Exercise period: anytime



08.04.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Germany
Internet:     www.stada.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------